Wyndham Hotels & Resorts (WH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
2024 saw record system-wide room growth of 3.6% and a 5% increase in the global development pipeline to 252,000 rooms, with a record-high global franchisee retention rate of 95.7%.
Opened over 500 hotels, expanded in key markets, and launched Wyndham Connect, a guest engagement platform leveraging technology for personalized experiences and operational efficiency.
Achieved diluted EPS of $3.61, adjusted EPS of $4.33, net income of $289M, adjusted net income of $347M, and adjusted EBITDA of $694M.
Returned $430M to shareholders in 2024 through $122M in dividends and $308M in stock repurchases.
Recognized among Newsweek’s “America’s Most Loved Workplaces” and Ethisphere’s “World’s Most Ethical Companies” for 2025.
Voting matters and shareholder proposals
Election of eight directors for terms expiring at the 2026 annual meeting.
Advisory vote to approve executive compensation (say-on-pay).
Advisory vote on the frequency of the say-on-pay vote, with the board recommending an annual vote.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2025.
Board recommends voting FOR all director nominees, FOR executive compensation, FOR annual say-on-pay, and FOR auditor ratification.
Board of directors and corporate governance
Board consists of eight members, six of whom are independent; all directors stand for annual election.
Board committees: Audit, Compensation, Corporate Governance, and Executive; all committee members are independent.
Board leadership structure separates Chair and CEO roles; independent Lead Director provides additional oversight.
Board and management engaged with stockholders representing 74% of outstanding shares in 2024.
Corporate Governance Guidelines and Director Independence Criteria exceed NYSE standards.
Latest events from Wyndham Hotels & Resorts
- Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Record room growth, resilient earnings, and strong capital returns despite RevPAR headwinds.WH
Q4 202519 Feb 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 202418 Jan 2026 - Record system growth, strong earnings, and new initiatives drive a positive 2025 outlook.WH
Q4 202429 Dec 2025 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.WH
Proxy Filing1 Dec 2025 - Record room and pipeline growth, but 2025 guidance lowered on RevPAR softness.WH
Q1 20251 Dec 2025 - System and pipeline growth offset RevPAR declines, driving higher earnings and strong cash returns.WH
Q3 202524 Oct 2025